Risks associated with drug-eluting stents

Affiliations

¹ Department of Medicine, Cardiology Section, Länssjukhuset i Kalmar, S-391 85 Kalmar, Sweden. Electronic address: jorgc@ltkalmar.se.
² University Hospital Umeå, Department of Cardiology, Umeå, Sweden.

Comment

Jörg Carlsson et al. Lancet. 2007.

. 2007 May 26;369(9575):1785.

doi: 10.1016/S0140-6736(07)60804-6.

¹ Department of Medicine, Cardiology Section, Länssjukhuset i Kalmar, S-391 85 Kalmar, Sweden. Electronic address: jorgc@ltkalmar.se.
² University Hospital Umeå, Department of Cardiology, Umeå, Sweden.

No abstract available

Comment on

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.
Daemen J, Wenaweser P, Tsuchida K, Abrecht L, Vaina S, Morger C, Kukreja N, Jüni P, Sianos G, Hellige G, van Domburg RT, Hess OM, Boersma E, Meier B, Windecker S, Serruys PW. Daemen J, et al. Lancet. 2007 Feb 24;369(9562):667-78. doi: 10.1016/S0140-6736(07)60314-6. Lancet. 2007. PMID: 17321312